US FDA okays arthritis drug for treatment of COVID-19
Actemra is a monoclonal antibody that reduces inflammation and is given by intravenous infusion that is FDA-approved for multiple inflammatory diseases, including rheumatoid arthritis.
Jun 27, 2021, 13:02 PM IST